optical mapping
Bionano Genomics Q1 Revenues Almost Triple
The San Diego-based optical genome mapping instrument maker saw record consumables revenue and beat Wall Street's consensus estimate on the top line.
Columbia University-led Study Highlights Bionano Optical Genome Mapping Concordance with Cytogenetics
Bionano Genomics called the study, presented this week at the American College for Medical Genetics meeting, an "incredibly important milestone" for the company.
The company is also working on a new Saphyr system that will have 14 times higher throughput than the current one, which can analyze 5,000 human genomes per year.
Bionano Genomics Q4 Revenues Grow 43 Percent
Revenues in Q4 totaled $4 million, up from $2.8 million a year ago, primarily driven by the firm's recently acquired Lineagen diagnostic services business.
Bionano Genomics to Raise $200M in Public Stock Offering
The new fundraising effort follows on the heels of a $101.8 million public stock offering Bionano closed last week, at a price of $3.05 per share.